Williams & Novak’s iShares Core MSCI International Developed Markets ETF IDEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$556K Sell
6,210
-240
-4% -$21.9K 0.33% 67
2026
Q2
$574K Hold
6,450
– – 0.38% 69
2026
Q1
$547K Hold
6,450
– – 0.41% 63
2025
Q4
$532K Hold
6,450
– – 0.4% 62
2025
Q3
$517K Hold
6,450
– – 0.4% 62
2025
Q2
$490K Sell
6,450
-1,600
-20% -$116K 0.42% 65
2025
Q1
$556K Sell
8,050
-235
-3% -$16K 0.54% 47
2024
Q4
$534K Sell
8,285
-100
-1% -$6.75K 0.52% 52
2024
Q3
$594K Sell
8,385
-1,000
-11% -$67.8K 0.55% 48
2024
Q2
$616K Sell
9,385
-1,585
-14% -$105K 0.57% 45
2024
Q1
$698K Hold
10,970
– – 0.79% 37
2023
Q4
$698K Buy
+10,970
New +$654K 0.79% 37

Other funds holding IDEV

Williams & Novak's IDEV Position: Q3 2026 in Review

Williams & Novak reduced its iShares Core MSCI International Developed Markets ETF (IDEV) stake by 3.7% in Q3 2026, selling an estimated $21.9K and leaving 6,210 shares worth $556K. The position accounts for 0.33% of the portfolio, ranked #67.

Williams & Novak first reported a position in IDEV in Q4 2023 and has held it in 12 quarters since. The position peaked at $698K in Q1 2024. 194 funds tracked by Wall St. Rank hold IDEV as of Q3 2026.

  • Williams & Novak held 6,210 shares of iShares Core MSCI International Developed Markets ETF worth $556K as of Q3 2026.
  • Williams & Novak sold 240 iShares Core MSCI International Developed Markets ETF shares in Q3 2026, an estimated $21.9K.
  • iShares Core MSCI International Developed Markets ETF made up 0.33% of Williams & Novak's portfolio in Q3 2026, its #67 holding.
  • Williams & Novak first reported a position in iShares Core MSCI International Developed Markets ETF in Q4 2023 and has held it in 12 quarters since.
  • Williams & Novak's iShares Core MSCI International Developed Markets ETF position peaked at $698K in Q1 2024.
  • 194 funds tracked by Wall St. Rank held iShares Core MSCI International Developed Markets ETF as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.